Connection
Cari Berget to Insulin
This is a "connection" page, showing publications Cari Berget has written about Insulin.
|
|
Connection Strength |
|
|
|
|
|
1.603 |
|
|
|
-
Berget C, Lange S, Messer L, Forlenza GP. A clinical review of the t:slim X2 insulin pump. Expert Opin Drug Deliv. 2020 12; 17(12):1675-1687.
Score: 0.368
-
Berget C, Thomas SE, Messer LH, Thivener K, Slover RH, Wadwa RP, Alonso GT. A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic. J Diabetes Sci Technol. 2020 03; 14(2):290-296.
Score: 0.332
-
Sherr JL, Schoelwer M, Dos Santos TJ, Reddy L, Biester T, Galderisi A, van Dyk JC, Hilliard ME, Berget C, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery. Pediatr Diabetes. 2022 12; 23(8):1406-1431.
Score: 0.108
-
Messer LH, Berget C. Hybrid Closed-Loop Systems to Date: Hype Versus Reality. Diabetes Technol Ther. 2023 01; 25(1):91-94.
Score: 0.106
-
Berget C, Akturk HK, Messer LH, Vigers T, Pyle L, Snell-Bergeon J, Driscoll KA, Forlenza GP. Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use. Diabetes Obes Metab. 2021 09; 23(9):2048-2057.
Score: 0.097
-
Ekhlaspour L, Schoelwer MJ, Forlenza GP, DeBoer MD, Norlander L, Hsu L, Kingman R, Boranian E, Berget C, Emory E, Buckingham BA, Breton MD, Wadwa RP. Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers. Diabetes Technol Ther. 2021 05; 23(5):384-391.
Score: 0.094
-
Wyckoff L, Berget C. The Use of Technology in Managing Diabetes in Youth Part 3-Special Considerations: Integration Into the School Setting. NASN Sch Nurse. 2020 Sep; 35(5):254-259.
Score: 0.092
-
Berget C, Wyckoff L. The Use of Technology in Managing Diabetes in Youth Part 2-Insulin Pump Technologies: Information and Tips for the School Nurse. NASN Sch Nurse. 2020 Jul; 35(4):188-195.
Score: 0.090
-
Berget C, Messer LH, Vigers T, Frohnert BI, Pyle L, Wadwa RP, Driscoll KA, Forlenza GP. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatr Diabetes. 2020 03; 21(2):310-318.
Score: 0.088
-
Messer LH, Berget C, Centi S, Mcnair B, Forlenza GP. Evaluation of a New Clinical Tool to Enhance Clinical Care of Control-IQ Users. J Diabetes Sci Technol. 2023 11; 17(6):1602-1609.
Score: 0.025
-
Forlenza GP, Vigers T, Berget C, Messer LH, Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM, Wadwa RP, Driscoll KA, Pyle L. Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study. Diabetes Technol Ther. 2022 03; 24(3):157-166.
Score: 0.025
-
Messer LH, Berget C, Pyle L, Vigers T, Cobry E, Driscoll KA, Forlenza GP. Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes Technol Ther. 2021 12; 23(12):837-843.
Score: 0.024
-
Messer LH, Berget C, Ernst A, Towers L, Slover RH, Forlenza GP. Initiating hybrid closed loop: A program evaluation of an educator-led Control-IQ follow-up at a large pediatric clinic. Pediatr Diabetes. 2021 06; 22(4):586-593.
Score: 0.024
-
Forlenza GP, Buckingham BA, Brown SA, Bode BW, Levy CJ, Criego AB, Wadwa RP, Cobry EC, Slover RJ, Messer LH, Berget C, McCoy S, Ekhlaspour L, Kingman RS, Voelmle MK, Boyd J, O'Malley G, Grieme A, Kivilaid K, Kleve K, Dumais B, Vienneau T, Huyett LM, Lee JB, O'Connor J, Benjamin E, Ly TT. First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2021 06; 23(6):410-424.
Score: 0.024
-
Cobry EC, Berget C, Messer LH, Forlenza GP. Review of the Omnipod? 5 Automated Glucose Control System Powered by Horizon? for the treatment of Type 1 diabetes. Ther Deliv. 2020 08; 11(8):507-519.
Score: 0.023
-
Sherr JL, Buckingham BA, Forlenza GP, Galderisi A, Ekhlaspour L, Wadwa RP, Carria L, Hsu L, Berget C, Peyser TA, Lee JB, O'Connor J, Dumais B, Huyett LM, Layne JE, Ly TT. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technol Ther. 2020 03; 22(3):174-184.
Score: 0.022
-
Messer LH, Berget C, Forlenza GP. A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm. Diabetes Technol Ther. 2019 08; 21(8):462-469.
Score: 0.021
-
O'Donnell HK, Berget C, Wooldridge JS, Driscoll KA. Graduated exposure to treat fear of hypoglycemia in a young adult with type 1 diabetes: A case study. Pediatr Diabetes. 2019 02; 20(1):113-118.
Score: 0.020
-
Reid MW, Krishnan S, Berget C, Cain C, Thomas JF, Klingensmith GJ, Raymond JK. CoYoT1 Clinic: Home Telemedicine Increases Young Adult Engagement in Diabetes Care. Diabetes Technol Ther. 2018 05; 20(5):370-379.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|